OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-09-30 $853
2024-06-30 $585
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.003B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.066B 26.11
Intuitive Surgical (ISRG) United States $211.086B 110.36
Alcon (ALC) Switzerland $41.615B 27.84
Edwards Lifesciences (EW) United States $41.156B 26.14
IQVIA Holdings (IQV) United States $35.821B 19.74
IDEXX Laboratories (IDXX) United States $34.331B 40.43
DexCom (DXCM) United States $32.958B 49.63
Waters (WAT) United States $23.988B 35.47
STERIS (STE) Ireland $20.691B 23.82
SONOVA HOLDING (SONVY) Switzerland $19.710B 0.00
Hologic (HOLX) United States $15.740B 17.09
Fresenius Medical Care AG KGaA (FMS) Germany $13.538B 13.90
Globus Medical (GMED) United States $12.364B 31.31
Sysmex ADR (SSMXY) Japan $11.726B 0.00
Penumbra (PEN) United States $10.120B 99.13
Masimo (MASI) United States $9.225B 44.63
Glaukos (GKOS) United States $8.623B 0.00
Teleflex (TFX) United States $8.419B 13.43
Integer Holdings (ITGR) United States $4.729B 26.81
Inari Medical (NARI) United States $4.657B 0.00
PROCEPT BioRobotics (PRCT) United States $3.967B 0.00
Veracyte (VCYT) United States $3.145B 94.37
Nihon Kohden (NHNKY) Japan $2.658B 20.19
LivaNova (LIVN) United Kingdom $2.623B 15.14
Tandem Diabetes Care (TNDM) United States $2.309B 0.00
Elekta AB (EKTAY) Sweden $2.167B 19.48
TransMedics (TMDX) United States $1.920B 60.85
Integra LifeSciences Holdings (IART) United States $1.860B 9.72
Alphatec Holdings (ATEC) United States $1.641B 0.00
Artivion (AORT) United States $1.288B 85.33
RxSight (RXST) United States $1.225B 0.00
Pulse Biosciences (PLSE) United States $1.083B 0.00
Paragon 28 (FNA) United States $0.911B 0.00
AxoGen (AXGN) United States $0.796B 0.00
Mesa Laboratories (MLAB) United States $0.758B 17.88
IRadimed (IRMD) United States $0.750B 40.53
AVANOS MEDICAL, INC (AVNS) United States $0.732B 12.44
SiBone (SIBN) United States $0.700B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.693B 0.00
OrthoPediatrics (KIDS) United States $0.658B 0.00
Semler Scientific (SMLR) United States $0.599B 31.55
Treace Medical Concepts (TMCI) United States $0.543B 0.00
AngioDynamics (ANGO) United States $0.503B 0.00
Delcath Systems (DCTH) United States $0.458B 0.00
Pacific Biosciences Of California (PACB) United States $0.449B 0.00
CVRx (CVRX) United States $0.428B 0.00
Tactile Systems Technology (TCMD) United States $0.418B 22.60
ClearPoint Neuro (CLPT) United States $0.415B 0.00
NeuroPace (NPCE) United States $0.357B 0.00
Alpha Tau Medical (DRTS) Israel $0.273B 0.00
Inogen (INGN) United States $0.249B 0.00
Accuray (ARAY) United States $0.225B 0.00
Anteris Technologies Global (AVR) Australia $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.187B 0.00
Nevro (NVRO) United States $0.171B 0.00
Sight Sciences (SGHT) United States $0.144B 0.00
Sensus Healthcare (SRTS) United States $0.108B 11.51
Atossa Genetics (ATOS) United States $0.104B 0.00
908 Devices (MASS) United States $0.104B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
LENSAR (LNSR) United States $0.097B 0.00
Vicarious Surgical (RBOT) United States $0.094B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Neuronetics (STIM) United States $0.075B 0.00
WORK Medical Technology Group (WOK) China $0.073B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
InspireMD (NSPR) Israel $0.071B 0.00
Covalon Technologies (CVALF) Canada $0.059B 30.93
Baird Medical Investment Holdings (BDMD) $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.050B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Microbot Medical (MBOT) United States $0.033B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.027B 0.00
NexGel (NXGL) United States $0.024B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
Ekso Bionics Holdings (EKSO) United States $0.014B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.008B 0.00
Check-Cap (CHEK) Israel $0.008B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
T2 Biosystems (TTOO) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00